Skip to main content

Table 2 Time on mood stabilizing treatment since baseline and retention rates during the study

From: Comparably high retention and low relapse rates in different subpopulations of bipolar patients in a German non-interventional study

Cohort N Mean [days] 95% CI [days] SD [days] 1st Quartile [days] Median [days] 3rd Quartile [days] Retention-Rate (%) 95% CI (%)
OM 186 433.5 408.4 - 458.5 173.0 335 520 548 88.1 82.1 - 92.1
LM 152 481.3 458.7 - 504.0 141.2 486 534 554 93.6 88.0 - 96.6
AM 216 440.4 416.8 - 464.0 175.8 363 527 558 83.8 77.8 - 88.3
OLC 47 475.1 428.4 - 521.8 159.1 454 538 570 87.1 73.4 - 94.0
OAC 68 417.5 371.1 - 463.9 191.8 262 514 552 86.8 75.2 - 93.2
OC 48 462.2 413.9 - 510.5 166.3 403 529 568 84.2 69.7; 92.2
OMS 44 377.5 318.8 - 436.2 193.1 230 484 531 85.9 71.3; 93.4
Total sample 761 444.7 432.5 - 456.9 171.2 374 525 554 87.7 85.1 - 90.0
  1. Abbreviations: OM Olanzapine monotherapy, LM Lithium monotherapy, AM Anticonvulsive monotherapy, OLC Olanzapine/lithium combination therapy, OAC Olanzapine/anticonvulsive combination therapy, OC Other combinations of mood-stabilizers, OMS Other mood stabilizing therapy, SD standard deviation, CI confidence interval.
  2. Start date was start of documentation. The end date was date of either the first discontinuation or switch of mood stabilizing medication, death, or the last documented visit.